These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9491318)

  • 1. Cytogenetic and molecular analysis of a t(1;22)(p36;q11.2) in a rhabdoid tumor with a putative homozygous deletion of chromosome 22.
    Rosty C; Peter M; Zucman J; Validire P; Delattre O; Aurias A
    Genes Chromosomes Cancer; 1998 Feb; 21(2):82-9. PubMed ID: 9491318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Narrowing the critical region for a rhabdoid tumor locus in 22q11.
    Biegel JA; Allen CS; Kawasaki K; Shimizu N; Budarf ML; Bell CJ
    Genes Chromosomes Cancer; 1996 Jun; 16(2):94-105. PubMed ID: 8818656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification of the breakpoint-flanking markers on chromosomes 1 and 17 of a constitutional translocation T(1;17)(P36;Q12-21) in a patient with neuroblastoma].
    Laureys GG
    Verh K Acad Geneeskd Belg; 1995; 57(5):389-422. PubMed ID: 8571670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 22q dosage in composite extrarenal rhabdoid tumors: clonal evolution or a phenotypic mimic?
    Fuller CE; Pfeifer J; Humphrey P; Bruch LA; Dehner LP; Perry A
    Hum Pathol; 2001 Oct; 32(10):1102-8. PubMed ID: 11679945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translocation (1;22)(p36;q11.2) with concurrent del(22)(q11.2) resulted in homozygous deletion of SNF5/INI1 in a newly established cell line derived from extrarenal rhabdoid tumor.
    Misawa A; Hosoi H; Imoto I; Iehara T; Sugimoto T; Inazawa J
    J Hum Genet; 2004; 49(10):586-589. PubMed ID: 15378398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel rearrangement of chromosome band 22q11.2 causing 22q11 microdeletion syndrome-like phenotype and rhabdoid tumor of the kidney.
    Wieser R; Fritz B; Ullmann R; Müller I; Galhuber M; Storlazzi CT; Ramaswamy A; Christiansen H; Shimizu N; Rehder H
    Hum Mutat; 2005 Aug; 26(2):78-83. PubMed ID: 15957176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity at chromosome regions 22q11-12 and 11p15.5 in renal rhabdoid tumors.
    Schofield DE; Beckwith JB; Sklar J
    Genes Chromosomes Cancer; 1996 Jan; 15(1):10-7. PubMed ID: 8824720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and molecular characterization of five cell lines derived from renal and extrarenal malignant rhabdoid tumors.
    Rosson GB; Hazen-Martin DJ; Biegel JA; Willingham MC; Garvin AJ; Oswald BW; Wainwright L; Brownlee NA; Wright CF
    Mod Pathol; 1998 Dec; 11(12):1228-37. PubMed ID: 9872656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12.1) in a neuroblastoma patient. Establishment of somatic cell hybrids and identification of PND/A12M2 on chromosome 1 and NF1/SCYA7 on chromosome 17 as breakpoint flanking single copy markers.
    Laureys G; Speleman F; Versteeg R; van der Drift P; Chan A; Leroy J; Francke U; Opdenakker G; Van Roy N
    Oncogene; 1995 Mar; 10(6):1087-93. PubMed ID: 7700633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the recurrent translocation t(1;1)(p36.3;q21.1-2) in non-Hodgkin lymphoma by multicolor banding and fluorescence in situ hybridization analysis.
    Lestou VS; Ludkovski O; Connors JM; Gascoyne RD; Lam WL; Horsman DE
    Genes Chromosomes Cancer; 2003 Apr; 36(4):375-81. PubMed ID: 12619161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular sublocalization and characterization of the 11;22 translocation breakpoint in a malignant rhabdoid tumor.
    Newsham I; Daub D; Besnard-Guerin C; Cavenee W
    Genomics; 1994 Feb; 19(3):433-40. PubMed ID: 8188285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of a consistent 4.5-megabase deletion at 4q28 in prostate cancer cells.
    Matsui S; LaDuca J; Rossi MR; Nowak NJ; Cowell JK
    Cancer Genet Cytogenet; 2005 May; 159(1):18-26. PubMed ID: 15860352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Philadelphia chromosome of a constitutional der(22)t(Y;22)(q11.2;p11) with a variant t(1;9;22)(p36;q34;q11) in a case of chronic myelogenous leukemia.
    Buijs A; Terhal PA; Thunnissen PL
    Cancer Genet Cytogenet; 2006 Jul; 168(1):80-2. PubMed ID: 16772126
    [No Abstract]   [Full Text] [Related]  

  • 14. Rearrangements of chromosome band 1p36 in non-Hodgkin's lymphoma.
    Dave BJ; Hess MM; Pickering DL; Zaleski DH; Pfeifer AL; Weisenburger DD; Armitage JO; Sanger WG
    Clin Cancer Res; 1999 Jun; 5(6):1401-9. PubMed ID: 10389925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The t(11;22)(p15.5;q11.23) in a retroperitoneal rhabdoid tumor also includes a regional deletion distal to CRYBB2 on 22q.
    Besnard-Guérin C; Cavenee W; Newsham I
    Genes Chromosomes Cancer; 1995 Jul; 13(3):145-50. PubMed ID: 7669732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence in situ hybridization dissection of a chronic myeloid leukemia case bearing the apparently balanced translocations (9;22)(q34;q11.2) and (11;11)(p15;q13).
    Malvestiti F; Colombo D; Perego D; Rodeschini O; Finelli P; Larizza L; Giardino D
    Cancer Genet Cytogenet; 2009 Jan; 188(1):42-7. PubMed ID: 19061779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9.
    Bennour A; Sennana H; Laatiri MA; Elloumi M; Khelif A; Saad A
    Cancer Genet Cytogenet; 2009 Oct; 194(1):30-7. PubMed ID: 19737651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cytogenetic characterization of proximal-type epithelioid sarcoma.
    Lualdi E; Modena P; Debiec-Rychter M; Pedeutour F; Teixeira MR; Facchinetti F; Dagrada GP; Pilotti S; Sozzi G
    Genes Chromosomes Cancer; 2004 Nov; 41(3):283-90. PubMed ID: 15334553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant rhabdoid tumor of the kidney: involvement of chromosome 22.
    Shashi V; Lovell MA; von Kap-herr C; Waldron P; Golden WL
    Genes Chromosomes Cancer; 1994 May; 10(1):49-54. PubMed ID: 7519873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetic alterations and gene expression profile of a malignant rhabdoid tumor of the kidney.
    Nagata T; Takahashi Y; Ishii Y; Asai S; Sugahara-Kobayashi M; Nishida Y; Murata A; Yamamori S; Ogawa Y; Nakamura T; Murakami H; Nakamura M; Shichino H; Chin M; Sugito K; Ikeda T; Koshinaga T; Mugishima H
    Cancer Genet Cytogenet; 2005 Dec; 163(2):130-7. PubMed ID: 16337855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.